Australians who bought a packet of Nurofen between 2011 and 2015 could be entitled to a slice of a $3.5 million settlement reached over misleading packaging.
Bannister Law on Wednesday confirmed that the consumer class action had been settled with drug company Reckitt Benckiser, who manufactures the Specific Pain Range at the centre of the suit.
In a statement the law firm said plans to use the money to reimburse eligible consumers, while notices regarding the compensation should be published in Australian newspapers imminently.
The result comes after the ACCC successfully argued that four of the range's products – for back pain, period pain, migraines and tension headaches – were chemically identical, breaching the country's consumer law.
"Nurofen Australia apologises to our consumers who may have been misled by the Nurofen Specific Pain Range packaging," the company said in a statement to AAP on Wednesday.
"Nurofen has offered to settle the Specific Pain Range class action in Australia to ensure that consumers who may have been misled are appropriately and swiftly compensated."
Last year a judge fined Reckitt Renckiser $6 million for the packaging, which has since been changed.
The reimbursement scheme is subject to final approval in the Federal Court.